methyleugenol has been researched along with Experimental Hepatoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auerbach, SS; Hoenerhoff, MJ; Hong, HL; Kovi, RC; Merrick, BA; Pandiri, AR; Phadke, D; Shah, R; Sills, RC; Taxman, DJ; Ton, TV; Xu, M | 1 |
Carmichael, PL; Crooks, NH; Waddell, WJ | 1 |
2 other study(ies) available for methyleugenol and Experimental Hepatoma
Article | Year |
---|---|
Exome Sequencing of Fresh-frozen or Formalin-fixed Paraffin-embedded B6C3F1/N Mouse Hepatocellular Carcinomas Arising Either Spontaneously or due to Chronic Chemical Exposure.
Topics: Animals; Carcinogens; Cryopreservation; DNA, Neoplasm; Eugenol; Exome; Female; Formaldehyde; Gene Expression Profiling; Ginkgo biloba; Liver; Liver Neoplasms, Experimental; Male; Mice, Inbred Strains; Mutation; Paraffin Embedding; Plant Extracts; Reproducibility of Results; Sequence Analysis, DNA; Tissue Fixation | 2018 |
Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats.
Topics: Animals; Breast Neoplasms; Carcinogens; Data Collection; DNA Adducts; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; England; Eugenol; Female; Humans; Liver Neoplasms, Experimental; Male; Phosphorus Isotopes; Rats; Rats, Inbred F344; Rats, Wistar; Risk Assessment; Statistics as Topic; Tamoxifen; United States; United States Food and Drug Administration | 2004 |